245 related articles for article (PubMed ID: 35740222)
1. Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach.
Barbarossa A; Rosato A; Corbo F; Clodoveo ML; Fracchiolla G; Carrieri A; Carocci A
Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740222
[TBL] [Abstract][Full Text] [Related]
2. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
[TBL] [Abstract][Full Text] [Related]
3. New Antimicrobial Approaches: Reuse of Old Drugs.
Savoia D
Curr Drug Targets; 2016; 17(6):731-8. PubMed ID: 26245476
[TBL] [Abstract][Full Text] [Related]
4. Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning.
Glajzner P; Bernat A; Jasińska-Stroschein M
Front Pharmacol; 2024; 15():1397602. PubMed ID: 38910882
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance.
Lagadinou M; Onisor MO; Rigas A; Musetescu DV; Gkentzi D; Assimakopoulos SF; Panos G; Marangos M
Antibiotics (Basel); 2020 Mar; 9(3):. PubMed ID: 32131427
[TBL] [Abstract][Full Text] [Related]
6. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
7. Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Franco LN; de Paula BR; Hörner R
World J Microbiol Biotechnol; 2021 Feb; 37(3):53. PubMed ID: 33604693
[TBL] [Abstract][Full Text] [Related]
8. Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms.
Alves de Lima E Silva A; Rio-Tinto A
Interdiscip Perspect Infect Dis; 2024; 2024():9109041. PubMed ID: 38586592
[TBL] [Abstract][Full Text] [Related]
9. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
Zacchino SA; Butassi E; Cordisco E; Svetaz LA
Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Properties of Antidepressants and Antipsychotics-Possibilities and Implications.
Caldara M; Marmiroli N
Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577614
[TBL] [Abstract][Full Text] [Related]
11. Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs.
Zacchino SA; Butassi E; Liberto MD; Raimondi M; Postigo A; Sortino M
Phytomedicine; 2017 Dec; 37():27-48. PubMed ID: 29174958
[TBL] [Abstract][Full Text] [Related]
12. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.
Chan EWL; Yee ZY; Raja I; Yap JKY
J Glob Antimicrob Resist; 2017 Sep; 10():70-74. PubMed ID: 28673701
[TBL] [Abstract][Full Text] [Related]
15. Repurposed drug candidates for antituberculosis therapy.
An Q; Li C; Chen Y; Deng Y; Yang T; Luo Y
Eur J Med Chem; 2020 Apr; 192():112175. PubMed ID: 32126450
[TBL] [Abstract][Full Text] [Related]
16. Repurposing approved drugs on the pathway to novel therapies.
Schein CH
Med Res Rev; 2020 Mar; 40(2):586-605. PubMed ID: 31432544
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
Roy S; Dhaneshwar S; Bhasin B
Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown D
Nat Rev Drug Discov; 2015 Dec; 14(12):821-32. PubMed ID: 26493767
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
